Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)

Lawrence W. Elmer; Jorge L. Juncos; Carlos Singer; Daniel D. Truong; Susan R. Criswell; Sotirios Parashos; Larissa Felt; Reed Johnson; Rajiv Patni

doi:10.1007/s40263-018-0510-z

Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)

Lawrence W. Elmer, Jorge L. Juncos, Carlos Singer, Daniel D. Truong, Susan R. Criswell, Sotirios Parashos, Larissa Felt, Reed Johnson, Rajiv Patni

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted.

Original language	English (US)
Pages (from-to)	399-400
Number of pages	2
Journal	CNS Drugs
Volume	32
Issue number	4
DOIs	https://doi.org/10.1007/s40263-018-0510-z
State	Published - Apr 1 2018

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1007/s40263-018-0510-z

Fingerprint Dive into the research topics of 'Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)'. Together they form a unique fingerprint.

Cite this

Elmer, L. W., Juncos, J. L., Singer, C., Truong, D. D., Criswell, S. R., Parashos, S., Felt, L., Johnson, R., & Patni, R. (2018). Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4). CNS Drugs, 32(4), 399-400. https://doi.org/10.1007/s40263-018-0510-z

Erratum to : Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4). / Elmer, Lawrence W.; Juncos, Jorge L.; Singer, Carlos; Truong, Daniel D.; Criswell, Susan R.; Parashos, Sotirios; Felt, Larissa; Johnson, Reed; Patni, Rajiv.

In: CNS Drugs, Vol. 32, No. 4, 01.04.2018, p. 399-400.

Research output: Contribution to journal › Comment/debate › peer-review

Elmer, LW, Juncos, JL, Singer, C, Truong, DD, Criswell, SR, Parashos, S, Felt, L, Johnson, R & Patni, R 2018, 'Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)', CNS Drugs, vol. 32, no. 4, pp. 399-400. https://doi.org/10.1007/s40263-018-0510-z

Elmer, Lawrence W. ; Juncos, Jorge L. ; Singer, Carlos ; Truong, Daniel D. ; Criswell, Susan R. ; Parashos, Sotirios ; Felt, Larissa ; Johnson, Reed ; Patni, Rajiv. / Erratum to : Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4). In: CNS Drugs. 2018 ; Vol. 32, No. 4. pp. 399-400.

@article{cf65a68d3ae24b01840aefd939f8674e,

title = "Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson{\textquoteright}s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)",

abstract = "An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted.",

author = "Elmer, {Lawrence W.} and Juncos, {Jorge L.} and Carlos Singer and Truong, {Daniel D.} and Criswell, {Susan R.} and Sotirios Parashos and Larissa Felt and Reed Johnson and Rajiv Patni",

year = "2018",

month = apr,

day = "1",

doi = "10.1007/s40263-018-0510-z",

language = "English (US)",

volume = "32",

pages = "399--400",

journal = "CNS Drugs",

issn = "1172-7047",

publisher = "Adis International Ltd",

number = "4",

}

TY - JOUR

T1 - Erratum to

T2 - Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)

AU - Elmer, Lawrence W.

AU - Juncos, Jorge L.

AU - Singer, Carlos

AU - Truong, Daniel D.

AU - Criswell, Susan R.

AU - Parashos, Sotirios

AU - Felt, Larissa

AU - Johnson, Reed

AU - Patni, Rajiv

PY - 2018/4/1

Y1 - 2018/4/1

N2 - An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted.

AB - An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted.

UR - http://www.scopus.com/inward/record.url?scp=85045134233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045134233&partnerID=8YFLogxK

U2 - 10.1007/s40263-018-0510-z

DO - 10.1007/s40263-018-0510-z

M3 - Comment/debate

C2 - 29637528

AN - SCOPUS:85045134233

VL - 32

SP - 399

EP - 400

JO - CNS Drugs

JF - CNS Drugs

SN - 1172-7047

IS - 4

ER -